Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Contemporary use of SGLT2 inhibitors in heart failure patients with diabetes mellitus: a comparison of DPP4 inhibitors in a nationwide electric health database of the superaged society

Fig. 2

Kaplan–Meier analysis of all-cause mortality (a) and HF readmission (b) for SGLT2 and DPP4 inhibitor use at discharge in overall patients and in patients aged ≥ 75 years. DPP4-I, dipeptidyl peptidase-4 inhibitor; HF, heart failure: SGLT2-I, sodium-glucose cotransporter-2 inhibitor

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840